BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11988839)

  • 1. The human p73 promoter: characterization and identification of functional E2F binding sites.
    Seelan RS; Irwin M; van der Stoop P; Qian C; Kaelin WG; Liu W
    Neoplasia; 2002; 4(3):195-203. PubMed ID: 11988839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the p53-homologue p73 in E2F1-induced apoptosis.
    Stiewe T; Pützer BM
    Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage induces transcriptional activation of p73 by removing C-EBPalpha repression on E2F1.
    Marabese M; Vikhanskaya F; Rainelli C; Sakai T; Broggini M
    Nucleic Acids Res; 2003 Nov; 31(22):6624-32. PubMed ID: 14602923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the 5'flanking region of the human Chk1 gene: identification of E2F1 functional sites.
    Carrassa L; Broggini M; Vikhanskaya F; Damia G
    Cell Cycle; 2003; 2(6):604-9. PubMed ID: 14504477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased DeltaN-p73 expression in tumors by upregulation of the E2F1-regulated, TA-promoter-derived DeltaN'-p73 transcript.
    Pützer BM; Tuve S; Tannapfel A; Stiewe T
    Cell Death Differ; 2003 May; 10(5):612-4. PubMed ID: 12728260
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential regulation of E2F1 apoptotic target genes in response to DNA damage.
    Pediconi N; Ianari A; Costanzo A; Belloni L; Gallo R; Cimino L; Porcellini A; Screpanti I; Balsano C; Alesse E; Gulino A; Levrero M
    Nat Cell Biol; 2003 Jun; 5(6):552-8. PubMed ID: 12766778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
    Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
    PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC; Pützer B; Schwabe G; Gnauck HK; Schulte Holthausen H
    Cell Mol Biol Res; 1993; 39(8):705-16. PubMed ID: 7951410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E1A activates transcription of p73 and Noxa to induce apoptosis.
    Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
    J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
    Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
    Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of p14ARF, p53, and p73 genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.
    Nicholson SA; Okby NT; Khan MA; Welsh JA; McMenamin MG; Travis WD; Jett JR; Tazelaar HD; Trastek V; Pairolero PC; Corn PG; Herman JG; Liotta LA; Caporaso NE; Harris CC
    Cancer Res; 2001 Jul; 61(14):5636-43. PubMed ID: 11454718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of the human cytochrome c1 promoter is modulated by E2F.
    Luciakova K; Barath P; Li R; Zaid A; Nelson BD
    Biochem J; 2000 Oct; 351(Pt 1):251-6. PubMed ID: 10998368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for the p53 homologue p73 in E2F-1-induced apoptosis.
    Irwin M; Marin MC; Phillips AC; Seelan RS; Smith DI; Liu W; Flores ER; Tsai KY; Jacks T; Vousden KH; Kaelin WG
    Nature; 2000 Oct; 407(6804):645-8. PubMed ID: 11034215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncogenes induce and activate endogenous p73 protein.
    Zaika A; Irwin M; Sansome C; Moll UM
    J Biol Chem; 2001 Apr; 276(14):11310-6. PubMed ID: 11115495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1.
    Blais A; Monté D; Pouliot F; Labrie C
    J Biol Chem; 2002 Aug; 277(35):31679-93. PubMed ID: 12077144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of p63 and p73 expression.
    Waltermann A; Kartasheva NN; Dobbelstein M
    Oncogene; 2003 Aug; 22(36):5686-93. PubMed ID: 12944917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F.
    Ohtani K; Tsujimoto A; Ikeda M; Nakamura M
    Oncogene; 1998 Oct; 17(14):1777-85. PubMed ID: 9778043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.